Clinical Trials Logo

Filter by:
NCT ID: NCT06408883 Not yet recruiting - Clinical trials for Chronic Functional Constipation

Effect of Vibration Capsule on Different Subtypes of Functional Constipation

Start date: June 1, 2024
Phase:
Study type: Observational [Patient Registry]

This study is a multi-center prospective cohort study, which plans to include 600 patients with chronic functional constipation to treat with Vibrabot capsules and patients will be grouped according to subtypes. During the study, the patients' basic information, baseline constipation status and treatment information, capsule intake during treatment, and concomitant medication will be collected. During the treatment phase, patients follow the doctor's advice to receive Vibrabot capsule treatment and maintain stable dietary intake and exercise according to the constipation diagnosis and treatment guidelines. During the study, patients need to fill in the relevant information during the treatment in the electronic questionnaire in a timely and truthful manner. The treatment effect of the patients is evaluated by assessing the number of occurrences of spontaneous bowel movements (SBM) and complete spontaneous bowel movements (CSBM).

NCT ID: NCT06408779 Completed - Clinical trials for Mitral Valve Insufficiency

Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

Start date: August 1, 2023
Phase:
Study type: Observational

This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.

NCT ID: NCT06408636 Completed - Atrial Fibrillation Clinical Trials

Prognostic Role of LA Strain in Acute Myocardial Infarction

CMR-MI
Start date: September 2, 2019
Phase:
Study type: Observational

This is a single-center retrospective observational study in which we consecutively selected patients diagnosed with acute myocardial infarction from September 2019 to March 2024 at the Affiliated Hospital of Xuzhou Medical University. Inclusion criteria: 1. CMR was completed during all hospitalizations; 2. complete clinical data; 3. received continuous cardiac monitoring during hospitalization. Exclusion criteria: 1. unclear or non-compliant CMR images; 2. previous history of myocardial infarction; 3. malignant tumors diseases. Dedicated cardiovascular imaging software CVI42 (cvi42® version 5.13.5, Circle Cardiovascular Imaging, Canada) was used for image analysis. LA strain was obtained by cardiac MRI feature tracking. Patient prognosis was obtained through chart notes and telephone follow-up. Major events included atrial fibrillation, ischemic stroke, and all-cause mortality.

NCT ID: NCT06408584 Recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

SCHRT
Start date: March 1, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study was to explore the safety and efficacy of short course hypofractionated radiotherapy combined with Raltitrexed and Tislelizumab in the treatment of patients with relapsed or advanced esophageal squamous cell carcinoma.

NCT ID: NCT06408571 Enrolling by invitation - Clinical trials for Metabolomics; Retinopathy; Etiology

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Start date: September 7, 2023
Phase:
Study type: Observational

Through the analysis of metabolites in body fluids (intraocular fluid, plasma) of patients with retinal vascular diseases (retinal vein occlusion, diabetic retinopathy), the possible pathogenesis of retinal vein occlusion was explored.

NCT ID: NCT06408415 Not yet recruiting - Cognition Clinical Trials

A Study of the Higher Cognitive Functions of the Human Brain With Single-neuron Activity Recording

Start date: May 2024
Phase:
Study type: Observational

This study aims to investigate that neural activity of higher cognitve function of human brain with hyperflexible neural electrode-cortex

NCT ID: NCT06408285 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects

Start date: May 2024
Phase: Phase 1
Study type: Interventional

This is a dose escalation trial. The dosing regimen involves a single-dose study. This is a single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetic characteristics of TQC3927 powder for inhalation in healthy adults subjects.

NCT ID: NCT06407986 Recruiting - Clinical trials for Lung Function Decreased

Pulmonary Ventilation Heterogeneity Determined by EIT During PFT in Subjects With Normal One-second Rates

Start date: May 15, 2024
Phase:
Study type: Observational [Patient Registry]

To evaluate the demographic characteristics of normal one-second rates population in patients with pulmonary function tests recommended by outpatient physicians. To investigate whether EIT can identify spatial and temporal heterogeneity of lung ventilation in individuals with normal one-second rates during pulmonary function testing. To investigate the distribution patterns of lung ventilation in individuals with normal one-second rates using this technique, and provide references and evidence for early screening, diagnosis, treatment monitoring, and prognostic evaluation.

NCT ID: NCT06407960 Completed - Clinical trials for Foot Function Index, Flat Foot, Dynamic Plantar Pressure, Reliability, Validity

The Clinical Study of Foot Function Index in Adolescent Flatfoot

Start date: January 1, 2022
Phase:
Study type: Observational

Using dynamic plantar pressure data during walking, combined with the FFI scores of adolescents, aids doctors and rehabilitation therapists in conducting more accurate, objective, and scientific evaluations of the functional parameters of the foot for appropriate rehabilitation treatment. Clinical studies on flat feet mainly focus on imaging diagnosis, gait characteristics, orthopedic insole studies, and different surgical treatment schemes related to flat foot injuries. However, few studies have analyzed the dynamic plantar pressure characteristics of flat feet to guide clinical interventions, as well as the correlation between the subjective perception of FFI and objective biomechanical parameter characteristics to analyze the validity of FFI and elucidate the physiological characteristics of foot diseases. Specific purpose of this study Therefore, the purpose of our study was to clarify the reliability and validity of the application of the FFI in flatfoot and the correlation between the FFI and dynamic plantar pressure.

NCT ID: NCT06407947 Recruiting - Multiple Myeloma Clinical Trials

Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma

Start date: June 6, 2024
Phase: Early Phase 1
Study type: Interventional

This trial is a single-arm, single-center, open-label clinical trial to evaluate the safety, efficacy, and metabolism kinetics of CT071 in patients with high-risk newly diagnosed multiple myeloma.